Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant vs Sequential Docetaxel + Gemcitabine in Breast Cancer
NCT00294385Phase 3Completed
- Sponsor
- Central European Cooperative Oncology Group
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of docetaxel, gemcitabine in breast cancer, sponsored by Central European Cooperative Oncology Group. Started Jun 2002; status: completed.
02
Drugs
docetaxelgemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00294385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294385.